Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Roxane Tussiwand is active.

Publication


Featured researches published by Roxane Tussiwand.


Nature Reviews Immunology | 2014

Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny

Martin Guilliams; Florent Ginhoux; Claudia V. Jakubzick; Shalin H. Naik; Nobuyuki Onai; Barbara U. Schraml; Elodie Segura; Roxane Tussiwand; Simon Yona

The mononuclear phagocyte system (MPS) has historically been categorized into monocytes, dendritic cells and macrophages on the basis of functional and phenotypical characteristics. However, considering that these characteristics are often overlapping, the distinction between and classification of these cell types has been challenging. In this Opinion article, we propose a unified nomenclature for the MPS. We suggest that these cells can be classified primarily by their ontogeny and secondarily by their location, function and phenotype. We believe that this system permits a more robust classification during both steady-state and inflammatory conditions, with the benefit of spanning different tissues and across species.


Proceedings of the National Academy of Sciences of the United States of America | 2006

Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2-/-gamma c-/- mice.

Stefan Baenziger; Roxane Tussiwand; Erika Schlaepfer; Luca Mazzucchelli; Mathias Heikenwalder; Michael O. Kurrer; Silvia Behnke; Joachim Frey; Annette Oxenius; Helen Joller; Adriano Aguzzi; Markus G. Manz; Roberto F. Speck

Because of species selectivity, HIV research is largely restricted to in vitro or clinical studies, both limited in their ability to rapidly assess new strategies to fight the virus. To prospectively study some aspects of HIV in vivo, immunodeficient mice, transplanted with either human peripheral blood leukocytes or human fetal tissues, have been developed. Although these are susceptible to HIV infection, xenoreactivity, and short infection spans, resource and ethical constraints, as well as biased HIV coreceptor tropic strain infection, pose substantial problems in their use. Rag2−/−γc−/− mice, transplanted as newborns with human CD34+ cells, were recently shown to develop human B, T, and dendritic cells, constituting lymphoid organs in situ. Here we tested these mice as a model system for HIV-1 infection. HIV RNA levels peaked to up to 2 × 106 copies per milliliter of plasma early after infection, and viremia was observed for up to 190 days, the longest time followed. A marked relative CD4+ T cell depletion in peripheral blood occurred in CXCR4-tropic strain-infected mice, whereas this was less pronounced in CCR5-tropic strain-infected animals. Thymus infection was almost exclusively observed in CXCR4-tropic strain-infected mice, whereas spleen and lymph node HIV infection occurred irrespective of coreceptor selectivity, consistent with respective coreceptor expression on human CD4+ T cells. Thus, this straightforward to generate and cost-effective in vivo model closely resembles HIV infection in man and therefore should be valuable to study virus-induced pathology and to rapidly evaluate new approaches aiming to prevent or treat HIV infection.


Nature | 2012

Compensatory dendritic cell development mediated by BATF-IRF interactions

Roxane Tussiwand; Wan-Ling Lee; Theresa L. Murphy; Mona Mashayekhi; Wumesh Kc; Jörn C. Albring; Ansuman T. Satpathy; Jeffrey A. Rotondo; Brian T. Edelson; Nicole M. Kretzer; Xiaodi Wu; Leslie A. Weiss; Elke Glasmacher; Peng Li; Wei Liao; Michael S. Behnke; Samuel S.K. Lam; Cora T. Aurthur; Warren J. Leonard; Harinder Singh; Christina L. Stallings; L. David Sibley; Robert D. Schreiber; Kenneth M. Murphy

The AP1 transcription factor Batf3 is required for homeostatic development of CD8α+ classical dendritic cells that prime CD8 T-cell responses against intracellular pathogens. Here we identify an alternative, Batf3-independent pathway in mice for CD8α+ dendritic cell development operating during infection with intracellular pathogens and mediated by the cytokines interleukin (IL)-12 and interferon-γ. This alternative pathway results from molecular compensation for Batf3 provided by the related AP1 factors Batf, which also functions in T and B cells, and Batf2 induced by cytokines in response to infection. Reciprocally, physiological compensation between Batf and Batf3 also occurs in T cells for expression of IL-10 and CTLA4. Compensation among BATF factors is based on the shared capacity of their leucine zipper domains to interact with non-AP1 factors such as IRF4 and IRF8 to mediate cooperative gene activation. Conceivably, manipulating this alternative pathway of dendritic cell development could be of value in augmenting immune responses to vaccines.


Nature Reviews Immunology | 2013

Specificity through cooperation: BATF-IRF interactions control immune-regulatory networks

Theresa L. Murphy; Roxane Tussiwand; Kenneth M. Murphy

Basic leucine zipper transcription factor ATF-like (BATF), BATF2 and BATF3 belong to the activator protein 1 (AP-1) family of transcription factors, which regulate numerous cellular processes. Initially, BATF family members were thought to function only as inhibitors of AP-1-driven transcription, but recent studies have uncovered that these factors have unique, non-redundant and positive transcriptional activities in dendritic cells, B cells and T cells. The question of how BATF and BATF3 — which lack a transcriptional activation domain, unlike the AP-1 factors FOS and JUN — can exert unique positive transcriptional specificity has now been answered by the discovery that BATF molecules interact with members of the interferon-regulatory factor (IRF) family. The capacity of the BATF leucine zipper regions to mediate dimerization with AP-1 factors and also to define cooperative interactions with heterologous factors explains both the positive transcriptional activity of BATF proteins and how they activate distinct sets of target genes compared with FOS.


Journal of Experimental Medicine | 2006

Activation of the Flt3 signal transduction cascade rescues and enhances type I interferon–producing and dendritic cell development

Nobuyuki Onai; Aya Obata-Onai; Roxane Tussiwand; Antonio Lanzavecchia; Markus G. Manz

Flt3 ligand (Flt3L) is a nonredundant cytokine in type I interferon–producing cell (IPC) and dendritic cell (DC) development, and IPC and DC differentiation potential is confined to Flt3+ hematopoietic progenitor cells. Here, we show that overexpression of human Flt3 in Flt3− (Flt3−Lin−IL-7Rα−Thy1.1−c-Kit+) and Flt3+ (Flt3+Lin−IL-7Rα−Thy1.1−c-Kit+) hematopoietic progenitors rescues and enhances their IPC and DC differentiation potential, respectively. In defined hematopoietic cell populations, such as Flt3− megakaryocyte/erythrocyte-restricted progenitors (MEPs), enforced Flt3 signaling induces transcription of IPC, DC, and granulocyte/macrophage (GM) development–affiliated genes, including STAT3, PU.1, and G-/M-/GM-CSFR, and activates differentiation capacities to these lineages. Moreover, ectopic expression of Flt3 downstream transcription factors STAT3 or PU.1 in Flt3− MEPs evokes Flt3 receptor expression and instructs differentiation into IPCs, DCs, and myelomonocytic cells, whereas GATA-1 expression and consecutive megakaryocyte/erythrocyte development is suppressed. Based on these data, we propose a demand-regulated, cytokine-driven DC and IPC regeneration model, in which high Flt3L levels initiate a self-sustaining, Flt3-STAT3– and Flt3-PU.1–mediated IPC and DC differentiation program in Flt3+ hematopoietic progenitor cells.


Immunity | 2015

Klf4 Expression in Conventional Dendritic Cells Is Required for T Helper 2 Cell Responses

Roxane Tussiwand; Bart Everts; Gary E. Grajales-Reyes; Nicole M. Kretzer; Arifumi Iwata; Juhi Bagaitkar; Xiaodi Wu; Rachel Wong; David A. Anderson; Theresa L. Murphy; Edward J. Pearce; Kenneth M. Murphy

The two major lineages of classical dendritic cells (cDCs) express and require either IRF8 or IRF4 transcription factors for their development and function. IRF8-dependent cDCs promote anti-viral and T-helper 1 (Th1) cell responses, whereas IRF4-expressing cDCs have been implicated in controlling both Th2 and Th17 cell responses. Here, we have provided evidence that Kruppel-like factor 4 (Klf4) is required in IRF4-expressing cDCs to promote Th2, but not Th17, cell responses in vivo. Conditional Klf4 deletion within cDCs impaired Th2 cell responses during Schistosoma mansoni infection, Schistosoma egg antigen (SEA) immunization, and house dust mite (HDM) challenge without affecting cytotoxic T lymphocyte (CTL), Th1 cell, or Th17 cell responses to herpes simplex virus, Toxoplasma gondii, and Citrobacter rodentium infections. Further, Klf4 deletion reduced IRF4 expression in pre-cDCs and resulted in selective loss of IRF4-expressing cDCs subsets in several tissues. These results indicate that Klf4 guides a transcriptional program promoting IRF4-expressing cDCs heterogeneity.


Nature Immunology | 2015

Batf3 maintains autoactivation of Irf8 for commitment of a CD8α + conventional DC clonogenic progenitor

Gary E. Grajales-Reyes; Arifumi Iwata; Jörn C. Albring; Xiaodi Wu; Roxane Tussiwand; Wumesh Kc; Nicole M. Kretzer; Carlos G. Briseño; Vivek Durai; Prachi Bagadia; Malay Haldar; Jörg Schönheit; Frank Rosenbauer; Theresa L. Murphy; Kenneth M. Murphy

The transcription factors Batf3 and IRF8 are required for the development of CD8α+ conventional dendritic cells (cDCs), but the basis for their actions has remained unclear. Here we identified two progenitor cells positive for the transcription factor Zbtb46 that separately generated CD8α+ cDCs and CD4+ cDCs and arose directly from the common DC progenitor (CDP). Irf8 expression in CDPs required prior autoactivation of Irf8 that was dependent on the transcription factor PU.1. Specification of the clonogenic progenitor of CD8α+ cDCs (the pre-CD8 DC) required IRF8 but not Batf3. However, after specification of pre-CD8 DCs, autoactivation of Irf8 became Batf3 dependent at a CD8α+ cDC–specific enhancer with multiple transcription factor AP1-IRF composite elements (AICEs) within the Irf8 superenhancer. CDPs from Batf3−/− mice that were specified toward development into pre-CD8 DCs failed to complete their development into CD8α+ cDCs due to decay of Irf8 autoactivation and diverted to the CD4+ cDC lineage.


Annual Review of Immunology | 2016

Transcriptional Control of Dendritic Cell Development

Theresa L. Murphy; Gary E. Grajales-Reyes; Xiaodi Wu; Roxane Tussiwand; Carlos G. Briseño; Arifumi Iwata; Nicole M. Kretzer; Vivek Durai; Kenneth M. Murphy

The dendritic cells (DCs) of the immune system function in innate and adaptive responses by directing activity of various effector cells rather than serving as effectors themselves. DCs and closely related myeloid lineages share expression of many surface receptors, presenting a challenge in distinguishing their unique in vivo functions. Recent work has taken advantage of unique transcriptional programs to identify and manipulate murine DCs in vivo. This work has assigned several nonredundant in vivo functions to distinct DC lineages, consisting of plasmacytoid DCs and several subsets of classical DCs that promote different immune effector modules in response to pathogens. In parallel, a correspondence between human and murine DC subsets has emerged, underlying structural similarities for the DC lineages between these species. Recent work has begun to unravel the transcriptional circuitry that controls the development and diversification of DCs from common progenitors in the bone marrow.


PLOS ONE | 2009

Crucial Role for BAFF-BAFF-R Signaling in the Survival and Maintenance of Mature B Cells

Melanie Rauch; Roxane Tussiwand; Nabil Bosco; Antonius Rolink

Defects in the expression of either BAFF (B cell activating factor) or BAFF-R impairs B cell development beyond the immature, transitional type-1 stage and thus, prevents the formation of follicular and marginal zone B cells, whereas B-1 B cells remain unaffected. The expression of BAFF-R on all mature B cells might suggest a role for BAFF-R signaling also for their in vivo maintenance. Here, we show that, 14 days following a single injection of an anti-BAFF-R mAb that prevents BAFF binding, both follicular and marginal zone B cell numbers are drastically reduced, whereas B-1 cells are not affected. Injection of control, isotype-matched but non-blocking anti-BAFF-R mAbs does not result in B cell depletion. We also show that this depletion is neither due to antibody-dependent cellular cytotoxicity nor to complement-mediated lysis. Moreover, prevention of BAFF binding leads to a decrease in the size of the B cell follicles, an impairment of a T cell dependent humoral immune response and a reduction in the formation of memory B cells. Collectively, these results establish a central role for BAFF-BAFF-R signaling in the in vivo survival and maintenance of both follicular and marginal zone B cell pools.


Genes, Chromosomes and Cancer | 2004

Identification of preleukemic precursors of hyperdiploid acute lymphoblastic leukemia in cord blood

Ana Teresa Maia; Roxane Tussiwand; Giovanni Cazzaniga; Paolo Rebulla; Susan M. Colman; Andrea Biondi; Mel Greaves

Previous studies involving identical twins with concordant leukemia and retrospective scrutiny of archived neonatal blood spots have shown that common chromosome translocations of pediatric leukemia frequently arise before birth. The IGH/TCR clonotypic sequences used as surrogate molecular markers suggest this is also likely to be true for hyperdiploid acute lymphoblastic leukemia (ALL). Yet evidence that hyperdiploidy itself is an early or initiating event occurring prenatally has been limited. Now, however, we can provide direct evidence of this from our identification of CD34+/CD19+ B‐lineage progenitor cells with triploid chromosomes in the stored cord blood of an individual who subsequently developed hyperdiploid ALL.

Collaboration


Dive into the Roxane Tussiwand's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kenneth M. Murphy

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

Theresa L. Murphy

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

Gary E. Grajales-Reyes

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

Xiaodi Wu

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

Nicole M. Kretzer

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Arifumi Iwata

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

Carlos G. Briseño

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

Nobuyuki Onai

Tokyo Medical and Dental University

View shared research outputs
Researchain Logo
Decentralizing Knowledge